167 related articles for article (PubMed ID: 28324660)
21. Quantitative Size-Based Analysis of Tumor Spheroids and Responses to Therapeutics.
Thakuri PS; Gupta M; Plaster M; Tavana H
Assay Drug Dev Technol; 2019 Apr; 17(3):140-149. PubMed ID: 30958703
[TBL] [Abstract][Full Text] [Related]
22. High-throughput screening reveals higher synergistic effect of MEK inhibitor combinations in colon cancer spheroids.
Folkesson E; Niederdorfer B; Nakstad VT; Thommesen L; Klinkenberg G; Lægreid A; Flobak Å
Sci Rep; 2020 Jul; 10(1):11574. PubMed ID: 32665693
[TBL] [Abstract][Full Text] [Related]
23. Identification of agents that induce apoptosis of multicellular tumour spheroids: enrichment for mitotic inhibitors with hydrophobic properties.
Fayad W; Rickardson L; Haglund C; Olofsson MH; D'Arcy P; Larsson R; Linder S; Fryknäs M
Chem Biol Drug Des; 2011 Oct; 78(4):547-57. PubMed ID: 21726416
[TBL] [Abstract][Full Text] [Related]
24. High-content assays for characterizing the viability and morphology of 3D cancer spheroid cultures.
Sirenko O; Mitlo T; Hesley J; Luke S; Owens W; Cromwell EF
Assay Drug Dev Technol; 2015 Sep; 13(7):402-14. PubMed ID: 26317884
[TBL] [Abstract][Full Text] [Related]
25. High-throughput 3D spheroid culture and drug testing using a 384 hanging drop array.
Tung YC; Hsiao AY; Allen SG; Torisawa YS; Ho M; Takayama S
Analyst; 2011 Feb; 136(3):473-8. PubMed ID: 20967331
[TBL] [Abstract][Full Text] [Related]
26. Automated Assessment of Cancer Drug Efficacy On Breast Tumor Spheroids in Aggrewell™400 Plates Using Image Cytometry.
Mukundan S; Bell J; Teryek M; Hernandez C; Love AC; Parekkadan B; Chan LL
J Fluoresc; 2022 Mar; 32(2):521-531. PubMed ID: 34989923
[TBL] [Abstract][Full Text] [Related]
27. Optimization of Aqueous Biphasic Tumor Spheroid Microtechnology for Anti-Cancer Drug Testing in 3D Culture.
Lemmo S; Atefi E; Luker GD; Tavana H
Cell Mol Bioeng; 2014 Sep; 7(3):344-354. PubMed ID: 25221631
[TBL] [Abstract][Full Text] [Related]
28. The Influence of Antitumor Unsymmetrical Bisacridines on 3D Cancer Spheroids Growth and Viability.
Kulesza J; Pawłowska M; Augustin E
Molecules; 2021 Oct; 26(20):. PubMed ID: 34684841
[TBL] [Abstract][Full Text] [Related]
29. Multiplexing spheroid volume, resazurin and acid phosphatase viability assays for high-throughput screening of tumour spheroids and stem cell neurospheres.
Ivanov DP; Parker TL; Walker DA; Alexander C; Ashford MB; Gellert PR; Garnett MC
PLoS One; 2014; 9(8):e103817. PubMed ID: 25119185
[TBL] [Abstract][Full Text] [Related]
30. High-throughput screening with nanoimprinting 3D culture for efficient drug development by mimicking the tumor environment.
Yoshii Y; Furukawa T; Waki A; Okuyama H; Inoue M; Itoh M; Zhang MR; Wakizaka H; Sogawa C; Kiyono Y; Yoshii H; Fujibayashi Y; Saga T
Biomaterials; 2015 May; 51():278-289. PubMed ID: 25771018
[TBL] [Abstract][Full Text] [Related]
31. Formation of stable small cell number three-dimensional ovarian cancer spheroids using hanging drop arrays for preclinical drug sensitivity assays.
Raghavan S; Ward MR; Rowley KR; Wold RM; Takayama S; Buckanovich RJ; Mehta G
Gynecol Oncol; 2015 Jul; 138(1):181-9. PubMed ID: 25913133
[TBL] [Abstract][Full Text] [Related]
32. Generation of uniform-sized multicellular tumor spheroids using hydrogel microwells for advanced drug screening.
Lee JM; Park DY; Yang L; Kim EJ; Ahrberg CD; Lee KB; Chung BG
Sci Rep; 2018 Nov; 8(1):17145. PubMed ID: 30464248
[TBL] [Abstract][Full Text] [Related]
33. Generation of High-Throughput Three-Dimensional Tumor Spheroids for Drug Screening.
Griner LM; Gampa K; Do T; Nguyen H; Farley D; Hogan CJ; Auld DS; Silver SJ
J Vis Exp; 2018 Sep; (139):. PubMed ID: 30247463
[TBL] [Abstract][Full Text] [Related]
34. Screening for compounds that induce apoptosis of cancer cells grown as multicellular spheroids.
Herrmann R; Fayad W; Schwarz S; Berndtsson M; Linder S
J Biomol Screen; 2008 Jan; 13(1):1-8. PubMed ID: 18040052
[TBL] [Abstract][Full Text] [Related]
35. Bionic 3D spheroids biosensor chips for high-throughput and dynamic drug screening.
Wu Q; Wei X; Pan Y; Zou Y; Hu N; Wang P
Biomed Microdevices; 2018 Sep; 20(4):82. PubMed ID: 30220069
[TBL] [Abstract][Full Text] [Related]
36. Fully Automated One-Step Production of Functional 3D Tumor Spheroids for High-Content Screening.
Monjaret F; Fernandes M; Duchemin-Pelletier E; Argento A; Degot S; Young J
J Lab Autom; 2016 Apr; 21(2):268-80. PubMed ID: 26385905
[TBL] [Abstract][Full Text] [Related]
37. Formation of multicellular tumor spheroids induced by cyclic RGD-peptides and use for anticancer drug testing in vitro.
Akasov R; Zaytseva-Zotova D; Burov S; Leko M; Dontenwill M; Chiper M; Vandamme T; Markvicheva E
Int J Pharm; 2016 Jun; 506(1-2):148-57. PubMed ID: 27107900
[TBL] [Abstract][Full Text] [Related]
38. High-Throughput 3D Tumor Spheroid Array Platform for Evaluating Sensitivity of Proton-Drug Combinations.
Lee DW; Kim JE; Lee GH; Son A; Park HC; Oh D; Jo K; Choi C
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054773
[TBL] [Abstract][Full Text] [Related]
39. High-dose drug heat map analysis for drug safety and efficacy in multi-spheroid brain normal cells and GBM patient-derived cells.
Lee SY; Teng Y; Son M; Ku B; Moon HS; Tergaonkar V; Chow PK; Lee DW; Nam DH
PLoS One; 2021; 16(12):e0251998. PubMed ID: 34855773
[TBL] [Abstract][Full Text] [Related]
40. Multiplexed Viability Assays for High-Throughput Screening of Spheroids of Multiple Sizes.
Marimuthu M; Gervais T
Methods Mol Biol; 2023; 2644():435-447. PubMed ID: 37142939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
